Most cited papers from Chiesi (United States)

Chiesi (United States)

What are the most cited papers from Chiesi (United States)?

The most cited paper from Chiesi (United States) is "European Respiratory Society/American Thoracic Society technical statement: standardisation of the measurement of lung volumes, 2023 update" (Nirav R. Bhakta, Aisling McGowan, Kathryn Angela Ramsey et al., 2023), with 159 citations. Next come "Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs: Update, July 2010 to June 2014" (43) and "Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics" (36).

Published TypeFieldAccess

Showing 50 of 69 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	European Respiratory Society/American Thoracic Society technical statement: standardisation of the measurement of lung volumes, 2023 update Nirav R. Bhakta, Aisling McGowan, Kathryn Angela Ramsey et al. · European Respiratory Journal Open access	27 Jul 2023	159
2	Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs: Update, July 2010 to June 2014 Frank J. Sasinowski, Erika B. Panico, James E. Valentine · Therapeutic Innovation & Regulatory Science	29 Apr 2015	43
3	Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics Mark C. Liu, Bradley E. Chipps, Xavier Muñoz et al. · Respiratory Research Open access	10 May 2021	36
4	Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany – The TriOptimize Study Christian Geßner, Frederik Trinkmann, Sanaz Bahari Javan et al. · International Journal of COPD Open access	Dec 2022	27
5	Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation Dave Singh, Leonardo Michele Fabbri, Massimo Corradi et al. · European Respiratory Journal Open access	20 Feb 2019	24
6	Cangrelor Use Patterns and Transition to Oral P2Y 12 Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry Jennifer A. Rymer, Deepak L. Bhatt, Dominick Joseph Angiolillo et al. · Journal of the American Heart Association Open access	27 May 2022	22
7	Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis Henryk Mazurek, R. Chiron, Tereza Kucerova et al. · Pediatric Pulmonology	24 Jan 2014	22
8	2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( Part 1A – Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization Part 1B - Regulatory Agen Matt Szapacs et al. · Bioanalysis	Aug 2023	21
9	Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow® rapid and PARI LC Plus® nebulisers in cystic fibrosis patients Mirco Govoni, Gianluigi Poli, Daniela Acerbi et al. · Pulmonary Pharmacology & Therapeutics	8 Dec 2012	21
10	Efficacy of Zileuton in Patients with Asthma and History of Aspirin Sensitivity: A Retrospective Analysis of Data from Two Phase 3 Studies Tanya M. Laidlaw, Daniel J. Fuentes, Yi Wang · Journal of Allergy and Clinical Immunology	Feb 2017	16
11	Examining Variations in Surfactant Administration (ENVISION): A Neonatology Insights Pilot Project Priya Patel, Andrew Houck, Daniel Ángel Ramos Fuentes · Children Open access	28 Mar 2021	14
12	2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody (PART 1A – Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis Mike Baratta et al. · Bioanalysis Open access	2 May 2024	12
13	Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital Perspective Ivar S. Jensen, Elizabeth S C Wu, Philip L. Cyr et al. · American Journal of Cardiovascular Drugs Open access	31 Jul 2021	11
14	2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management; ELN Migration; Ultra-Sensitivity Mass Spectrometry ( Part 1A – Recommendations on Advanced Strategies for Mass Spectrometry Assays, Chromatography, Sample Preparation and BMV/Regulated Bioanalysis P John B. Wojcik et al. · Bioanalysis Open access	25 Jan 2025	10
15	Effects of inhaled beclometasone dipropionate/formoterol fumarate/glycopyrronium vs. beclometasone dipropionate/formoterol fumarate and placebo on lung hyperinflation and exercise endurance in chronic obstructive pulmonary disease: a randomised controlled trial Henrik Watz, Anne‐Marie Kirsten, Andrea Ludwig-Sengpiel et al. · Respiratory Research Open access	17 Oct 2024	10
16	Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations Alberto A. Papi, Stefano Petruzzelli, Stefano Vezzoli et al. · European Respiratory Journal Open access	Apr 2019	10
17	Aging and Susceptibility to Pulmonary Disease Julia Budde, Gwen S. Skloot · Comprehensive physiology	29 Jun 2022	8
18	CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD Mirco Govoni et al. · Respiratory Research Open access	19 Oct 2024	8
19	The Psychiatric Domain of Post-Intensive Care Syndrome: A Review for the Intensivist Allison Rhodes, Christopher Wilson, Dimitar Zelenkov et al. · Journal of Intensive Care Medicine	22 Aug 2024	8
20	COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US Fernando J. Martínez, Alberto A. Papi, Tobias Welte et al. · International Journal of COPD Open access	Jun 2024	7
21	Cangrelor PK/PD analysis in post‐operative neonatal cardiac patients at risk for thrombosis Diana Vargas, Hairu Zhou, Xinren Yu et al. · Journal of Thrombosis and Haemostasis Open access	20 Oct 2020	7
22	The Use of Cangrelor in Cardiogenic Shock: Insights from the CAMEO Registry Jennifer A. Rymer et al. · Journal of Cardiac Failure	Oct 2024	6
23	The effect of inhaled extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide on distal and central airway indices, assessed using Functional Respiratory Imaging in COPD (DARWiIN) Gwen S. Skloot, Alessandro Guasconi, Benjamin R. Lavon et al. · Respiratory Research Open access	6 Oct 2023	6
24	Patient-reported experience with Fabry disease and its management in the real-world setting: results from a double-blind, cross-sectional survey of 280 respondents Lisa Berry, Jerry Walter, Jack L. Johnson et al. · Orphanet Journal of Rare Diseases Open access	11 Apr 2024	5
25	Introduction to microneedles Ryan F. Donnelly, Ester Caffarel–Salvador, Harvinder Singh Gill et al. · Journal of Materials Chemistry B Open access	2023	5
26	Efficacy and Safety of Inhaled Glycopyrronium Bromide in COPD: A Randomized, Parallel Group, Dose-Ranging Study (GLIMMER) Edward Kerwin, Gregory Feldman, James L. Pearle et al. · COPD Journal of Chronic Obstructive Pulmonary Disease Open access	4 Mar 2021	5
27	Impact of a quality improvement intervention on neonatal mortality in a regional hospital in Burkina Faso Paul Ouédraogo, Paolo Ernesto Villani, Lucia Tubaldi et al. · The Journal of Maternal-Fetal & Neonatal Medicine Open access	5 Jan 2021	5
28	Influence of Treatment Effect Modifiers in Fabry Disease: A Systematic Literature Review Khashayar Azimpour, C. Tordoff-Gibson, Patricia Dorling et al. · Advances in Therapy ReviewOpen access	5 Dec 2024	4
29	Evaluation of Glycemic Variability and Discharge Outcomes in Patients with Ischemic Stroke Following Thrombolysis Mackenzie Steck, Drew A. Wells, Jaclyn M. Stoffel et al. · The Neurohospitalist Open access	19 Sep 2023	4
30	Health Economics of Selective Early Rescue Surfactant Administration and Standard Surfactant Administration for Newborns With Respiratory Distress Syndrome Weiyu Yao, Ivar S. Jensen, Marc Claussen et al. · The Journal of Pediatric Pharmacology and Therapeutics Open access	17 Nov 2022	4
31	Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO Registry Jennifer A. Rymer et al. · Journal of the Society for Cardiovascular Angiography & Interventions Open access	27 Nov 2023	3
32	P1511: EFFICACY AND SAFETY OF COMBINATION IRON CHELATION THERAPY WITH DEFERIPRONE AND DEFERASIROX IN PATIENTS WITH Β-THALASSEMIA MAJOR: A SYSTEMATIC LITERATURE REVIEW A. Piga, S. Sheth, A. Kattamis et al. · HemaSphere ReviewOpen access	Jun 2022	3
33	O3–06–05: Sustained cognitive benefit in patients with mild cognitive impairment (MCI) upon prolonged treatment with CHF5074 Joel Ross, Sanjiv Sharma, Abhijit Chatterjee et al. · Alzheimer s & Dementia	Jul 2013	3
34	Beclometasone Dipropionate/Formoterol Fumarate is Similarly Effective to Budesonide/Formoterol Fumarate in Chinese Patients with COPD: The FORSYYN Double-Blind, Randomised Study Fuqiang Wen, Yanmin Wu, Chunyan Xing et al. · COPD Journal of Chronic Obstructive Pulmonary Disease Open access	11 Nov 2024	2
35	Efficacy and safety of inhaled extrafine beclomethasone dipropionate in adults with asthma: a randomized, parallel-group, dose-ranging study (BEAM) Anthony J. Montanaro, Steven F. Weinstein, Carolyn Beaudot et al. · Journal of Asthma Open access	24 May 2021	2
36	Pharmacokinetics of tobramycin nebulizer solution (300mg/4ml) administered by Pari e-Flow rapid vs Pari LC plus nebulizer in patients with cystic fibrosis and Pseudomonas aeruginosa infection Mirco Govoni, Gianluigi Poli, HELEN G. CICIRELLO et al. · European Respiratory Journal	Sep 2012	2
37	Safety of Less Invasive Surfactant Administration in Preterm Infants: A Meta‐Analysis Xuezheng Sun, Shaked Yarza, Yuting Kuang et al. · Pediatric Pulmonology Open access	Jul 2026	1
38	A Pharmacist Consultant Service for Deprescribing Opioids and Benzodiazepines in Older Adults Jan Busby-Whitehead, Stefanie P. Ferreri, Joshua Niznik et al. · JAMA Network Open Open access	26 Feb 2026	1
39	Differences in healthcare resource utilization by race/ethnicity among moderate to late preterm infants with respiratory distress Syndrome, Northern California Xuezheng Sun, Sanjida J. Mowla, Annie N. Simpson et al. · Journal of Perinatology Open access	24 Feb 2026	1
40	Patient-, Clinician-, and Institution-level Variation in Intraoperative Antihypertensive Use: A Multicenter Observational Analysis Megan L. Rolfzen, Douglas A. Colquhoun, Nirav Shah et al. · Journal of Cardiothoracic and Vascular Anesthesia Open access	21 Feb 2026	1
41	Ultra-Early Blood Pressure Control in Acute Intracerebral Hemorrhage Janelle Poyant, Brianne M. Ritchie · Cardiology in Review	24 Mar 2025	1
42	9191 Real-world Biochemical And Symptoms Outcomes With Oral Octreotide: Management Of Acromegaly (MACRO) Registry Experience Kevin C.J. Yuen, Wenyu Huang, Maria Fleseriu et al. · Journal of the Endocrine Society Open access	Oct 2024	1
43	Impact of the addition of clinical pharmacy services to the cardiac catheterization laboratory Molly Kernan, Marion E Max, Brianne M. Ritchie et al. · American Journal of Health-System Pharmacy	24 Jul 2024	1
44	PB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THERAPY IN PATIENTS WITH THALASSEMIA SYNDROMES OR SICKLE CELL ANEMIA: A SYSTEMATIC LITERATURE REVIEW Antonios C. Kattamis, Janet Kwiatkowski, F. Tricta et al. · HemaSphere ReviewOpen access	Jun 2022	1
45	P3‐411: Safety and pharmacokinetics of CHF5074, a novel gamma‐secretase modulator, after single oral administration to healthy humans Bruno Pietro Imbimbo, Donna Mackintosh, Tara Aponte et al. · Alzheimer s & Dementia	Jul 2010	1
46	Efficacy of Less Invasive Surfactant Administration (LISA) in Preterm Neonates With Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis Xuezheng Sun, Shaked Yarza, Yuting Kuang et al. · Sage Open Pediatrics ReviewOpen access	Mar 2026	0
47	A23-13 Introducing the Patient Voice Into COPD Clinical Trial Design: Self-Reported Behaviour Change Post COVID-19 K Lu, A Gayle, G S Skloot et al. · American Journal of Respiratory and Critical Care Medicine	May 2026	0
48	An algorithm to identify less invasive surfactant administration using a real-world database of preterm infants Xuezheng Sun, Annie N. Simpson, Aditi Lahiri et al. · PLoS ONE Open access	15 Apr 2026	0
49	516: HYPERTENSION DURING CLEVIDIPINE INFUSION: DOSING INSIGHTS FOR BETTER ICU BLOOD PRESSURE MANAGEMENT Jeremy Pepino, Siyu Ma, Andrew Reisner · Critical Care Medicine	Mar 2026	0
50	100.45 Healthcare Resource Utilization and Costs Among Patients Receiving Cangrelor or Glycoprotein IIb/IIIa Inhibitors During Percutaneous Coronary Intervention in the United States Siyu Ma · JACC: Cardiovascular Interventions	Mar 2026	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.